The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics.
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
A plan to test the effectiveness of so-called “Frankenflies” is being closely watched by nearby Miami-Dade County as a possible way to combat the spread of Zika.
WikiLeaks documents show a cautious speaker who tried to avoid compromises on policy.
Efforts to control and track the mosquitoes that carry the Zika virus have been hampered by lack of resources.
As Miami-Dade doubles down on aerial spraying of the insecticide naled to combat the mosquitoes that spread Zika, experts question that approach.